ULTRALIFE CORP (ULBI) Fundamental Analysis & Valuation

NASDAQ:ULBI • US9038991025

Current stock price

6.52 USD
+0.39 (+6.36%)
At close:
6.65 USD
+0.13 (+1.99%)
After Hours:

This ULBI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. ULBI Profitability Analysis

1.1 Basic Checks

  • ULBI had positive earnings in the past year.
  • In the past year ULBI had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: ULBI reported negative net income in multiple years.
  • In multiple years ULBI reported negative operating cash flow during the last 5 years.
ULBI Yearly Net Income VS EBIT VS OCF VS FCFULBI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 0.77%, ULBI is in the better half of the industry, outperforming 67.39% of the companies in the same industry.
  • ULBI has a better Return On Equity (1.25%) than 68.48% of its industry peers.
  • The Return On Invested Capital of ULBI (3.21%) is better than 68.48% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for ULBI is significantly below the industry average of 9.33%.
Industry RankSector Rank
ROA 0.77%
ROE 1.25%
ROIC 3.21%
ROA(3y)1.39%
ROA(5y)0.8%
ROE(3y)1.97%
ROE(5y)1.13%
ROIC(3y)3.99%
ROIC(5y)N/A
ULBI Yearly ROA, ROE, ROICULBI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15 20

1.3 Margins

  • ULBI has a Profit Margin of 0.92%. This is in the better half of the industry: ULBI outperforms 69.57% of its industry peers.
  • ULBI has a better Operating Margin (4.20%) than 69.57% of its industry peers.
  • In the last couple of years the Operating Margin of ULBI has declined.
  • ULBI has a Gross Margin (23.89%) which is in line with its industry peers.
  • ULBI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.2%
PM (TTM) 0.92%
GM 23.89%
OM growth 3Y251.13%
OM growth 5Y-9.1%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.58%
GM growth 5Y-2.35%
ULBI Yearly Profit, Operating, Gross MarginsULBI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

6

2. ULBI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ULBI is destroying value.
  • Compared to 1 year ago, ULBI has about the same amount of shares outstanding.
  • The number of shares outstanding for ULBI has been increased compared to 5 years ago.
  • The debt/assets ratio for ULBI has been reduced compared to a year ago.
ULBI Yearly Shares OutstandingULBI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
ULBI Yearly Total Debt VS Total AssetsULBI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

2.2 Solvency

  • An Altman-Z score of 1.83 indicates that ULBI is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 1.83, ULBI is in line with its industry, outperforming 58.70% of the companies in the same industry.
  • The Debt to FCF ratio of ULBI is 5.62, which is a neutral value as it means it would take ULBI, 5.62 years of fcf income to pay off all of its debts.
  • ULBI's Debt to FCF ratio of 5.62 is fine compared to the rest of the industry. ULBI outperforms 73.91% of its industry peers.
  • A Debt/Equity ratio of 0.34 indicates that ULBI is not too dependend on debt financing.
  • With a decent Debt to Equity ratio value of 0.34, ULBI is doing good in the industry, outperforming 60.87% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 5.62
Altman-Z 1.83
ROIC/WACC0.43
WACC7.54%
ULBI Yearly LT Debt VS Equity VS FCFULBI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

2.3 Liquidity

  • A Current Ratio of 2.99 indicates that ULBI has no problem at all paying its short term obligations.
  • ULBI has a better Current ratio (2.99) than 75.00% of its industry peers.
  • ULBI has a Quick Ratio of 1.42. This is a normal value and indicates that ULBI is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of ULBI (1.42) is better than 60.87% of its industry peers.
Industry RankSector Rank
Current Ratio 2.99
Quick Ratio 1.42
ULBI Yearly Current Assets VS Current LiabilitesULBI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

3

3. ULBI Growth Analysis

3.1 Past

  • The earnings per share for ULBI have decreased strongly by -45.65% in the last year.
  • The Earnings Per Share has been growing by 71.00% on average over the past years. This is a very strong growth
  • Looking at the last year, ULBI shows a quite strong growth in Revenue. The Revenue has grown by 16.24% in the last year.
  • ULBI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.16% yearly.
EPS 1Y (TTM)-45.65%
EPS 3Y71%
EPS 5YN/A
EPS Q2Q%1100%
Revenue 1Y (TTM)16.24%
Revenue growth 3Y13.19%
Revenue growth 5Y12.16%
Sales Q2Q%10.55%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y279.44%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.24%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ULBI Yearly Revenue VS EstimatesULBI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M
ULBI Yearly EPS VS EstimatesULBI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 0.2 0.4 0.6 0.8

7

4. ULBI Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 26.08, the valuation of ULBI can be described as expensive.
  • ULBI's Price/Earnings ratio is rather cheap when compared to the industry. ULBI is cheaper than 80.43% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 24.75, ULBI is valued at the same level.
  • A Price/Forward Earnings ratio of 6.87 indicates a rather cheap valuation of ULBI.
  • Based on the Price/Forward Earnings ratio, ULBI is valued cheaply inside the industry as 97.83% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of ULBI to the average of the S&P500 Index (22.10), we can say ULBI is valued rather cheaply.
Industry RankSector Rank
PE 26.08
Fwd PE 6.87
ULBI Price Earnings VS Forward Price EarningsULBI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ULBI indicates a rather cheap valuation: ULBI is cheaper than 92.39% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, ULBI is valued cheaper than 96.74% of the companies in the same industry.
Industry RankSector Rank
P/FCF 12.13
EV/EBITDA 10.84
ULBI Per share dataULBI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • ULBI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.09
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. ULBI Dividend Analysis

5.1 Amount

  • No dividends for ULBI!.
Industry RankSector Rank
Dividend Yield 0%

ULBI Fundamentals: All Metrics, Ratios and Statistics

ULTRALIFE CORP

NASDAQ:ULBI (3/31/2026, 4:03:36 PM)

After market: 6.65 +0.13 (+1.99%)

6.52

+0.39 (+6.36%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)03-10
Earnings (Next)04-23
Inst Owners72.37%
Inst Owner Change-1.44%
Ins Owners3.2%
Ins Owner Change0.79%
Market Cap108.56M
Revenue(TTM)191.16M
Net Income(TTM)1.72M
Analysts82.86
Price TargetN/A
Short Float %0.53%
Short Ratio1.64
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-91.09%
Min EPS beat(2)-131.19%
Max EPS beat(2)-50.98%
EPS beat(4)0
Avg EPS beat(4)-72.67%
Min EPS beat(4)-131.19%
Max EPS beat(4)-15.03%
EPS beat(8)3
Avg EPS beat(8)-15.66%
EPS beat(12)5
Avg EPS beat(12)43.11%
EPS beat(16)7
Avg EPS beat(16)38.76%
Revenue beat(2)0
Avg Revenue beat(2)-13.21%
Min Revenue beat(2)-19.77%
Max Revenue beat(2)-6.65%
Revenue beat(4)2
Avg Revenue beat(4)-3.82%
Min Revenue beat(4)-19.77%
Max Revenue beat(4)7.48%
Revenue beat(8)5
Avg Revenue beat(8)-1.68%
Revenue beat(12)7
Avg Revenue beat(12)2.25%
Revenue beat(16)10
Avg Revenue beat(16)3.31%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 26.08
Fwd PE 6.87
P/S 0.58
P/FCF 12.13
P/OCF 8.65
P/B 0.79
P/tB 1.58
EV/EBITDA 10.84
EPS(TTM)0.25
EY3.83%
EPS(NY)0.95
Fwd EY14.55%
FCF(TTM)0.54
FCFY8.25%
OCF(TTM)0.75
OCFY11.56%
SpS11.2
BVpS8.24
TBVpS4.12
PEG (NY)0.09
PEG (5Y)N/A
Graham Number6.81
Profitability
Industry RankSector Rank
ROA 0.77%
ROE 1.25%
ROCE 4.15%
ROIC 3.21%
ROICexc 3.37%
ROICexgc 5.47%
OM 4.2%
PM (TTM) 0.92%
GM 23.89%
FCFM 4.8%
ROA(3y)1.39%
ROA(5y)0.8%
ROE(3y)1.97%
ROE(5y)1.13%
ROIC(3y)3.99%
ROIC(5y)N/A
ROICexc(3y)4.21%
ROICexc(5y)N/A
ROICexgc(3y)6.61%
ROICexgc(5y)N/A
ROCE(3y)5.17%
ROCE(5y)N/A
ROICexgc growth 3Y254.16%
ROICexgc growth 5Y-6.96%
ROICexc growth 3Y266.9%
ROICexc growth 5Y-6.86%
OM growth 3Y251.13%
OM growth 5Y-9.1%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.58%
GM growth 5Y-2.35%
F-Score5
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 5.62
Debt/EBITDA 3.52
Cap/Depr 66.95%
Cap/Sales 1.93%
Interest Coverage 250
Cash Conversion 95.05%
Profit Quality 521.01%
Current Ratio 2.99
Quick Ratio 1.42
Altman-Z 1.83
F-Score5
WACC7.54%
ROIC/WACC0.43
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-45.65%
EPS 3Y71%
EPS 5YN/A
EPS Q2Q%1100%
EPS Next Y279.44%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)16.24%
Revenue growth 3Y13.19%
Revenue growth 5Y12.16%
Sales Q2Q%10.55%
Revenue Next Year6.24%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-36.81%
EBIT growth 3Y297.46%
EBIT growth 5Y1.95%
EBIT Next Year50.3%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-34.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-21.67%
OCF growth 3YN/A
OCF growth 5YN/A

ULTRALIFE CORP / ULBI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ULTRALIFE CORP (ULBI) stock?

ChartMill assigns a fundamental rating of 5 / 10 to ULBI.


What is the valuation status for ULBI stock?

ChartMill assigns a valuation rating of 7 / 10 to ULTRALIFE CORP (ULBI). This can be considered as Undervalued.


Can you provide the profitability details for ULTRALIFE CORP?

ULTRALIFE CORP (ULBI) has a profitability rating of 4 / 10.


What are the PE and PB ratios of ULTRALIFE CORP (ULBI) stock?

The Price/Earnings (PE) ratio for ULTRALIFE CORP (ULBI) is 26.08 and the Price/Book (PB) ratio is 0.79.


What is the expected EPS growth for ULTRALIFE CORP (ULBI) stock?

The Earnings per Share (EPS) of ULTRALIFE CORP (ULBI) is expected to grow by 279.44% in the next year.